http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07258264-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
filingDate 1994-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43e3de1f9e412b3fd36a26275d8ae09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb071ce18e78b80482d66eb15a4892a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754500827a57394b0d677fcb41efc0f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0aab3e020546b52299badd957da105c
publicationDate 1995-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H07258264-A
titleOfInvention Method for reversing optically active 3,4-epoxy-3,4-dihydro-2H-1-benzopyran compounds to the corresponding enantiomers
abstract (57) [Summary] [Structure] [Chemical Formula 1] By the above process, the optically active 3,4-epoxy-3,4 A method of inverting a sihydro-2H-1-benzopyran compound (I) to the corresponding enantiomer (I ′). The method of the present invention can convert an optically active 3,4-epoxy-3,4-dihydro-2H-1-benzopyran compound into a corresponding enantiomer by an inexpensive and simple operation. It is possible to use the optically active substance other than the purpose obtained by the optical resolution method without waste.
priorityDate 1994-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456372957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10867360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448989919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457583645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410714557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13149033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230076634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54230877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415834534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426084234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420521830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18505459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457323082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21879635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456405831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208179

Total number of triples: 48.